Top Ovarian Cancer Research Leaders (KOLs) 2021-2026

Top research leaders (by recent publication volume)

#	Researcher	Affiliation	Papers
1	Ray-Coquard Isabelle	Centre Leon Berard and Université Claude Bernard	5
2	Zhang Yi	The Third Affiliated Hospital of Kunming Medical Universit	3
3	Ribeiro Reitan	McGill University Health Centre	3
4	Wang Yu	Sichuan Provincial People's Hospital	3
5	Zhang Jie	Longhua Hospital	3
6	Hu Lijuan	Shaanxi Provincial Cancer Hospital	3
7	Wang Guoqing	Shaanxi Provincial Cancer Hospital	3
8	Rhiem Kerstin	University of Cologne	3
9	Li Hui	Shaanxi Provincial Cancer Hospital	3
10	Leis Letícia Vecchi	Faculdade de Medicina da Universidade de São Paulo	3
11	Fagotti Anna	Fondazione Policlinico Universitario A. Gemelli IRCCS	3
12	Joly Florence	Centre Baclesse	3
13	Barretina-Ginesta Maria-Pilar	Institut Català d'Oncologia	3
14	Yamagami Wataru	Keio University School of Medicine	3
15	Li Yan	Tongji Hospital	3
16	Kurzrock Razelle	WIN Consortium Villejuif France.	2
17	Wang Xin	The Third Affiliated Hospital of Kunming Medical Universit	2
18	Hao Yuntao	Affiliated Hospital of Chengde Medical University	2

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

College of Medicine (13), University of California (7), The University of Texas MD Anderson Cancer Center (7), Brigham and Women's Hospital (6), Fudan University Shanghai Cancer Center (6), National Cancer Institute (6), University of Toronto (6), University College London (5), Women's Hospital (5), Emory University (5)

Active subtopics

Ovarian Neoplasms (104), Cell Line, Tumor (29), Biomarkers, Tumor (26), Retrospective Studies (22), Gene Expression Regulation, Neoplastic (22), Genital Neoplasms, Female (22), Antineoplastic Agents (19), Prognosis (16)

Top journals

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (19), Frontiers in oncology (14), Gynecologic oncology (14), International journal of molecular sciences (14), Scientific reports (11), Cureus (11)

Representative recent papers

Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and mole (2026) · PMID 42479110

Primary Fallopian Tube Carcinoma: Clinicopathological Characteristics, Therapeutic Management and Prognostic Factors in a Cohort o (2026) · PMID 42478978

Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer (2026) · PMID 42478879

WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers. (2026) · PMID 42478852

Uncovering the Underlying Mechanism of Clotrimazole against Ovarian Cancer by Transcriptomics and Experimental Investigations. (2026) · PMID 42478651

Want the full cited brief?

A full Ovarian Cancer brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us